Torrent Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹3,062.30(-1.10%)March 13, 2025 15:29:00 PM IST
- NSE
- BSE
- Vol : 171.01K (NSE + BSE)Last 20 day avg : 382.18 K
Torrent Pharmaceuticals is trading -1.10% lower at Rs 3,062.30 as compared to its last closing price. Torrent Pharmaceuticals has been trading in the price range of 3,099.10 & 3,040.30. Torrent Pharmaceuticals has given -9.05% in this year & -0.10% in the last 5 days. Torrent Pharmaceuticals has TTM P/E ratio 61.06 as compared to the sector P/E of 28.29.There are 25 analysts who have initiated coverage on Torrent Pharmaceuticals. There are 4 analysts who have given it a strong buy rating & 9 analysts have given it a buy rating. 4 analysts have given the stock a sell rating.The company posted a net profit of 503.00 Crores in its last quarter.Listed peers of Torrent Pharmaceuticals include Divis Laboratories (-0.95%), Cipla (0.53%), Torrent Pharmaceuticals (-1.10%).The Mutual Fund holding in Torrent Pharmaceuticals was at 4.88% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Torrent Pharmaceuticals was at 16.17% in 31 Dec 2024. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Mar 16, 2025, 10:49 AM UTC
- Dividend YieldInline with the industry1.05Annual dividends as a percentage of the stock price.
- P/BLower than historical values15.09The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values55.53Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.68Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.59The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 2.82% from Rs 2809.00 crore to Rs 2732.00 crore, year-on-year
- The company has grown its December quarter profit by 13.54% from Rs 443.00 crore to Rs 503.00 crore, year-on-year
The debt to equity of the company is higher than the industry median- Company can comfortably pay off its interest obligations with its earnings
- R1
- 3,091.38
- R2
- 3,237.47
- R3
- 3,337.43
- S1
- 2,845.33
- S2
- 2,745.37
- S3
- 2,599.28
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories | Neutral | 5,611.60 | -0.95 | 1,48,903.05 | 93.08 | 10.99 | 0.53 | 0.01 |
| Cipla | Neutral | 1,461.60 | 0.53 | 1,18,040.87 | 27.19 | 4.42 | 0.89 | 0.84 |
| Torrent Pharmaceuticals | Neutral | 3,062.30 | -1.10 | 1,03,637.50 | 64.51 | 15.09 | 1.05 | 24.33 |
| Dr Reddys Laboratories | Bearish | 1,107.85 | 0.24 | 92,439.57 | 16.77 | 3.27 | 0.72 | 2.12 |
| Lupin | Bearish | 1,964.00 | -0.06 | 89,652.87 | 43.39 | 6.28 | 0.41 | 1.09 |
- Promoter(s) holds a high stake in the company at 68.31%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has increased by 1.71 percentage points from previous quarter
- Mutual Funds holding has increased by 1.19 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-01-24 | Quarterly Results & Others |
| 2024-10-25 | Quarterly Results |
| 2024-07-23 | Quarterly Results |
| 2024-05-24 | Audited Results & Final Dividend |
| 2024-02-02 | Quarterly Results & Interim Dividend |
- IndustryBiotechnology & Drugs
- ISININE685A01028
- BSE Code500420
- NSE CodeTORNTPHARM
Torrent Pharmaceuticals is trading at 3062.30 as on Thu Mar 13 2025 09:59:00. This is -1.10% lower as compared to its previous closing price of 3096.25.
The market capitalization of Torrent Pharmaceuticals is 103637.50 Cr as on Thu Mar 13 2025 09:59:00.
The average broker rating on Torrent Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 4 analysts have given a strong buy rating
- 9 analysts have given a buy rating
- 7 analysts have given a hold rating
- 4 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Torrent Pharmaceuticals is 3589.95 whereas the 52 wk low is 2488.00
Torrent Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 61.06
- Sector P/E: 28.29
- Dividend Yield: 1.05%
- D/E ratio: -
Torrent Pharmaceuticals reported a net profit of 1656.38 Cr in 2024.
The Mutual Fund Shareholding was 4.88% at the end of 31 Dec 2024.